Exhibit 10.15
RETENTION BONUS AGREEMENT
THIS RETENTION BONUS AGREEMENT (this “Agreement”), is made and entered into by and between Finch Therapeutics Group, Inc., a Delaware corporation (together with all subsidiaries and affiliates hereinafter referred to as the “Company”), and Marc Blaustein (the “Executive”) effective as of December 7, 2022.
1
[Signature Page Follows]
2
IN WITNESS WHEREOF, the parties have executed this Retention Bonus Agreement as of the date first written above.
FINCH THERAPEUTICS GROUP, INC.
By:__/s/ Mark Smith____________________ Title: CEO
|
EXECUTIVE
|
/s/ Marc Blaustein_______________________ Marc Blaustein
|
3
EXHIBIT A
Performance Conditions
4